Navigation Links
Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio
Date:8/16/2010

Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio -- CLEVELAND, Ohio, August 16, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Computer Electronics, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Supplementary Medicine, Clinical Trials & Medical Discoveries, FDA Approval Click to view news release full screen  

Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio

 

CLEVELAND, Ohio, August 16, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, will consolidate its eTrinsic custom courseware business currently located in Denver, Colorado and relocate those operations to its Corporate Headquarters in Cleveland, Ohio under its expanding Medical Education Division (MED).

The move will enable Simbionix to better focus on its strategic direction, enhance its mobile and web-based medical education products and services, and improve reaction to customer and market needs. "This is a very exciting time for Simbionix", stated Paul Jensen, the GM of the new and expanding Medical Education Division, "we are developing a number of innovative products. Having everyone in one location will facilitate collaboration across the team and improve our ability to rapidly deliver high-quality solutions."

The company recently announced the expansion of its Corporate Headquarters. The move will be completed by the end of September 2010.

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com Contact: Rebecca Zitter Manager of Marketing Communications and Distributor Relations Rebecca@simbionix.com +1-216-229-2040
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Simbionix Continues its Global Expansion
2. Simbionix to Reveal Two new Products at the Upcoming American Urology Association (AUA) Annual Meeting
3. Simbionix ANGIO Mentor Plays Important Role in Physician Training and Certification
4. Simbionix USA Corporations Innovative Development Division Releases Two New Breakthrough Technologies
5. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
6. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
7. Simbionix Increases Product Offerings for OB/GYN Physicians
8. Glen C. Williams Joins eLearning Sales Team for Simbionix, Heading up Chicago Office
9. New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
10. William E. Lewandowski to Lead Simbionix US Marketing Team in Simbionixs Strategic Expansion in the US Market
11. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
Breaking Biology News(10 mins):